BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1352860 BLUE BELL, PA

Position in CRSP

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$5,508

+$704 QoQ

Shares Held

101

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#420

of 522 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 65% Shared 0% None 35%

Healthcare · as of Jun 30, 2026

BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC holds $146,305 across 4 Biotechnology names. CRSP ranks #4 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRME	Prime Medicine, Inc.	25,830	$95,312
2	NTLA	Intellia Therapeutics, Inc.	1,757	$29,728
3	INCY	Incyte Corp	139	$15,757
4	CRSP	CRISPR Therapeutics AG This page	101	$5,508

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,508	101	0.0%	Shares	Sole	2026-08-06
2026-03-31	$4,804	101	-38.0%	Shares	Sole	2026-05-11
2025-12-31	$8,547	163	+33.6%	Shares	Sole	2026-02-09
2025-09-30	$7,906	122	-41.1%	Shares	Sole	2025-10-22
2025-06-30	$10,068	207	0.0%	Shares	Sole	2025-08-11
2025-03-31	$7,044	207	0.0%	Shares	Sole	2025-05-05
2024-12-31	$8,147	207	0.0%	Shares	Sole	2025-02-07
2024-09-30	$9,724	207	0.0%	Shares	Sole	2024-10-29
2024-06-30	$11,180	207	+56.8%	Shares	Sole	2024-08-05
2024-03-31	$8,997	132	-37.7%	Shares	Sole	2024-04-24
2023-12-31	$13,271	212	0.0%	Shares	Sole	2024-01-25
2023-09-30	$9,622	212	0.0%	Shares	Sole	2023-10-30
2023-06-30	$11,901	212	0.0%	Shares	Sole	2023-08-08
2023-03-31	$9,588	212	+30.9%	Shares	Sole	2023-05-08
2022-12-31	$6,585	162	0.0%	Shares	Sole	2023-02-03
2022-09-30	$10,586	162	+6.6%	Shares	Sole	2022-11-09
2022-06-30	$9,237	152	-16.5%	Shares	Sole	2022-08-02
2022-03-31	$11,424	182	+61.1%	Shares	Sole	2022-04-21
2021-12-31	$8,563	113	—	Shares	Sole	2022-01-26
No filing history on record for this holder in this stock.